Literature DB >> 33577563

Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.

Susanna Hilda Hutajulu1, Daniel Howdon2, Kartika Widayati Taroeno-Hariadi1, Mardiah Suci Hardianti1, Ibnu Purwanto1, Sagung Rai Indrasari3, Camelia Herdini3, Bambang Hariwiyanto3, Ahmad Ghozali4, Henry Kusumo5, Wigati Dhamiyati5, Sri Retna Dwidanarti5, I Bing Tan3,6, Johan Kurnianda1, Matthew John Allsop2.   

Abstract

PURPOSE: This study aimed to determine the survival outcome and prognostic factors of patients with nasopharyngeal cancer accessing treatment in Yogyakarta, Indonesia.
METHODS: Data on 759 patients with NPC diagnosed from 2007 to 2016 at Dr Sardjito General Hospital were included. Potential prognostic variables included sociodemographic, clinicopathology and treatment parameters. Multivariable analyses were implemented using semi-parametric Cox proportional hazards modelling and fully parametric survival analysis.
RESULTS: The median time of observation was 14.39 months. In the whole cohort the median observed survival was 31.08 months. In the univariable analysis, age, education status, insurance type, BMI, ECOG index, stage and treatment strategy had an impact on overall survival (OS) (p values <0.01). Semi-parametric multivariable analyses with stage stratification showed that education status, ECOG index, and treatment modality were independent prognostic factors for OS (p values <0.05). In the fully parametric models age, education status, ECOG index, stage, and treatment modality were independent prognostic factors for OS (p values <0.05). For both multivariable analyses, all treatment strategies were associated with a reduced hazard (semi-parametric models, p values <0.05) and a better OS (parametric models, p values <0.05) compared with no treatment. Furthermore, compared with radiation alone or chemotherapy alone, a combination of chemotherapy and radiation either in a form of concurrent chemoradiotherapy (CCRT), sequential chemotherapy and radiation, or induction chemotherapy followed by CCRT demonstrated a reduced hazard (hazard ratio/HR 0.226, 95% confidence interval/CI 0.089-0.363, and HR 0.390, 95%CI 0.260-0.519) and a better OS (time ratio/TR 3.108, 95%CI 1.274-4.942 and TR 2.531, 95%CI 1.829-3.233) (p values < 0.01).
CONCLUSIONS: Median OS for the cohort was low compared to those reported in both endemic and non-endemic regions. By combining the findings of multivariable analyses, we showed that age, education status, ECOG index, stage and first treatment modality were independent predictors for the OS.

Entities:  

Year:  2021        PMID: 33577563      PMCID: PMC7880494          DOI: 10.1371/journal.pone.0246638

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  61 in total

Review 1.  Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

Authors:  Anne W M Lee; Wai Tong Ng; Lucy L K Chan; Wai Man Hung; Connie C C Chan; Henry C K Sze; Oscar S H Chan; Amy T Y Chang; Rebecca M W Yeung
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

2.  Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.

Authors:  Cheng Xu; Rui Sun; Ling-Long Tang; Lei Chen; Wen-Fei Li; Yan-Ping Mao; Guan-Qun Zhou; Rui Guo; Ai-Hua Lin; Ying Sun; Jun Ma; Wei-Han Hu
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

3.  Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.

Authors:  Miia Ruuskanen; Reidar Grenman; Ilmo Leivo; Tero Vahlberg; Antti Mäkitie; Kauko Saarilahti; Tuija Wigren; Merja Korpela; Leena Voutilainen; Petri Koivunen; Heikki Irjala; Heikki Minn
Journal:  Acta Oncol       Date:  2017-07-07       Impact factor: 4.089

4.  Nasopharyngeal carcinoma: a delay in diagnosis.

Authors:  U Prasad; K C Pua
Journal:  Med J Malaysia       Date:  2000-06

5.  ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.

Authors:  F Bozzetti; J Arends; K Lundholm; A Micklewright; G Zurcher; M Muscaritoli
Journal:  Clin Nutr       Date:  2009-05-23       Impact factor: 7.324

6.  Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study.

Authors:  Qing Liu; Jin-Ou Chen; Qi-Hong Huang; Yan-Hua Li
Journal:  Chin J Cancer       Date:  2012-12-13

7.  The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis.

Authors:  Mei Liu; Wei You; Yi-Bing Song; Ji-Dong Miao; Xiu-Bo Zhong; Dian-Kun Cai; Lun Xu; Lu-Feng Xie; Yang Gao
Journal:  Front Oncol       Date:  2018-12-19       Impact factor: 6.244

8.  Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma.

Authors:  Jing Chen; Tongxin Liu; Quanquan Sun; Fujun Hu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study.

Authors:  Tonje Braaten; Elisabete Weiderpass; Eiliv Lund
Journal:  BMC Public Health       Date:  2009-06-08       Impact factor: 3.295

10.  Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.

Authors:  Yun-Hsuan Lin; Tai-Lin Huang; Chih-Yen Chien; Hui-Chun Chen; Hsuan-Chih Hsu; Eng-Yen Huang; Chong-Jong Wang; Yu-Jie Huang; Yu-Ming Wang; Chun-Chieh Huang; Shang-Yu Chou; Kuan-Cho Liao; Fu-Min Fang
Journal:  Radiat Oncol       Date:  2018-03-20       Impact factor: 3.481

View more
  3 in total

1.  Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco.

Authors:  Ayman Reffai; Mohamed Mesmoudi; Touria Derkaoui; Naima Ghailani Nourouti; Amina Barakat; Nabila Sellal; Parag Mallick; Mohcine Bennani Mechita
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 2.  Efficacy of the Nourishing Yin and Clearing Heat Therapy Based on Traditional Chinese Medicine in the Prevention and Treatment of Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinomas: A Systematic Review and Meta-Analysis of Thirty Randomized Controlled Trials.

Authors:  Jinsheng Huang; Jun Kan; Teng Fan; Qi Quan; Xujia Li; Qi Jiang; Bei Zhang; Guifang Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-19       Impact factor: 2.650

3.  Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma.

Authors:  Tirta Wardana; Siti Nur Chasanah; Risky Oktriani; Cita Herawati; Sumadi Lukman Anwar; Indwiani Astuti; Sofia Mubarika Haryana
Journal:  Noncoding RNA Res       Date:  2022-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.